Development and Commercialisation Plan. 3.1.1 Within 90 days of the Commencement Date, the Joint Development Team shall prepare a written plan (“Development and Commercialisation Plan”) that expands upon the initial development plan set out in Schedule 3 and will describe, and provide a timeline for: (a) all development activities for the Licensed Product in the Oncoscience Field and Territory, addressing each phase of development and the budget for completion of such activities, and providing detailed information on the activities to be conducted in the next 12 month period; (b) intellectual property protection strategy, including applying for Orphan Drug Status, patents and supplementary protection certificates (c) sub-licensing strategy; (d) clinical and registration strategy, with a view to expediting regulatory approval for Licensed Product; and (e) commercialisation strategy. 3.1.2 The Joint Development Team shall update the Development and Commercialisation Plan on a regular basis (and at least annually).
Appears in 2 contracts
Samples: Development and Licence Agreement (Ym Biosciences Inc), Development and Licence Agreement (Ym Biosciences Inc)
Development and Commercialisation Plan. 3.1.1 4.1.1 Within 90 days of the Commencement Date, the Joint Development Team shall prepare a written plan (“"Development and Commercialisation Plan”") that expands upon the initial development plan set out in Schedule 3 and will describe, and provide a timeline for:
(a) all development activities for the Licensed Product in the Oncoscience Field and Territory, addressing each phase of development and the budget for completion of such activities, and providing detailed information on the activities to be conducted in the next 12 month period;
(b) intellectual property protection strategy, including applying for Orphan Drug Status, patents and supplementary protection certificates
(c) sub-licensing strategy;
(d) clinical and registration strategy, with a view to expediting regulatory approval for Licensed Product; and
(e) commercialisation strategy.
3.1.2 The Joint Development Team shall update the Development and Commercialisation Plan on a regular basis (and at least annually).
Appears in 2 contracts
Samples: Development and License Agreement (Ym Biosciences Inc), Development and License Agreement (Ym Biosciences Inc)
Development and Commercialisation Plan. 3.1.1 Within 90 days of the Commencement Date, the Joint Development Team shall prepare a written plan (“"Development and Commercialisation Plan”") that expands upon the initial development plan set sec out in Schedule 3 and will describe, and provide a timeline time line for:
(a) all development activities for the Licensed Product in the Oncoscience Kuhnil Field and Territory, addressing each phase of development and the budget for completion of such activities, and providing detailed information on the activities to be conducted in the next 12 12-month period;.
(b) intellectual property protection strategy, including applying for Orphan Drug Status, patents and supplementary protection certificates;
(c) sub-licensing strategy;
(d) clinical and registration strategy, with a view to expediting regulatory approval for Licensed ProductRegulatory Approval; and
(ed) commercialisation strategy.
3.1.2 . The Joint Development Team shall update the Development and Commercialisation Plan on a regular basis (and at least annually).
Appears in 1 contract
Samples: Development and License Agreement (Ym Biosciences Inc)
Development and Commercialisation Plan. 3.1.1 Within 90 days of the Commencement Date, the Joint Development Team shall prepare a written plan (“"Development and Commercialisation Plan”") that expands upon the initial development plan set sec out in Schedule 3 and will describe, and provide a timeline time line for:
(a) all development activities for the Licensed Product in the Oncoscience IGK Field and Territory, addressing each phase of development and the budget for completion of such activities, and providing detailed information on the activities to be conducted in the next 12 12-month period;.
(b) intellectual property protection strategy, including applying for Orphan Drug Status, patents and supplementary protection certificates;
(c) sub-licensing strategy;
(d) clinical and registration strategy, with a view to expediting regulatory approval for Licensed ProductRegulatory Approval; and
(ed) commercialisation strategy.
3.1.2 . The Joint Development Team shall update the Development and Commercialisation Plan on a regular basis (and at least annually).
Appears in 1 contract
Samples: Development and License Agreement (Ym Biosciences Inc)